Assyro AI

Orange Book product · Brand (NDA)

JANUMET

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Brand (NDA)NDA 022044TE ABRX MSD SUB MERCK

At a glance

Mar 30, 2007

Approved

Brand (NDA)

Application

AB

TE code

4

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 30, 2007

    19 yr 6 mo ago

  2. Today

  3. Patent 7326708 expires

    Listed drug substance patent expiration.

    Nov 24, 2026

    in 5 mo

  4. Patent 7326708*PED expires

    Listed listed patent expiration.

    May 24, 2027

    in 11 mo

  5. Patent 8414921 expires

    Listed drug product patent expiration.

    Jul 21, 2028

    in 2 yr 1 mo

  6. Patent 8414921*PED expires

    Listed listed patent expiration.

    Jan 21, 2029

    in 2 yr 8 mo

Pharmaceutical detail

Active ingredient

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Strength

1GM;EQ 50MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

NDA 022044

Product number

002

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7326708Nov 24, 2026in 5 mo
SubstanceProductU-802
7326708*PEDMay 24, 2027in 11 mo
8414921Jul 21, 2028in 2 yr 1 mo
ProductU-1036
8414921*PEDJan 21, 2029in 2 yr 8 mo
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.